Search - tctmd.com

Displaying 101 - 120 of 135

Sort: Relevancy | Date

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Daily News

Cath Lab Preactivated Less Than Half the Time in STEMI Cases: ACTION Registry

Michael O'Riordan

September 18, 2018

News Daily News

Hospital Readmissions at 30 Days Declining for Stroke Patients

Michael O'Riordan

August 20, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Gender-neutral criteria and better transparency around physician salaries are among proposals under consideration as a draft resolution moves ahead.

News Daily News

AMA Takes on Gender Inequity, Including the Wage Gap

Michael O'Riordan

June 15, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Conference News CRT 2018

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Michael O'Riordan

March 06, 2018

News Daily News

Women Have Higher Risk of Unplanned Readmission After PCI

Michael O'Riordan

January 12, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

Advertisement

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Cath Lab Preactivated Less Than Half the Time in STEMI Cases: ACTION Registry

Hospital Readmissions at 30 Days Declining for Stroke Patients

Discharge Against Medical Advice After PCI Rare but Deadly

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

AMA Takes on Gender Inequity, Including the Wage Gap

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Women Have Higher Risk of Unplanned Readmission After PCI

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Generic ARBs Linked to Increased Adverse Events

New Performance and Quality Metrics for STEMI and NSTEMI Care

Evolocumab Not Cost-Effective at Current List Price

TAVR in the US: Regional Variations in Numbers, Outcomes

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content